French pharmaceutical producer localizing production of another preparation in St. Petersburg

In autumn 2016, Ipsen (France) intends to start the production of Difereline, an anticancer drug, at Raduga Production, a Saint Petersburg-based factory.

French pharmaceutical producer localizing production of another preparation in St. Petersburg

In autumn 2016, Ipsen (France) intends to start the production of Difereline, an anticancer drug, at Raduga Production, a Saint Petersburg-based factory.

To localize the production of Difereline, Ipsen will migrate its production technology and analytical monitoring center to the St. Petersburg factory.

Last year, Ipsen launched a string at Raduga Production to produce Tanakan, an angioprotecive drug. The French company has invested several hundreds of Euros to arrange the production of Tanakan. According to the company's representatives, the localization of the medicinal production will allow cutting logistic costs by up to 15%.